Tag: Research
-
Northwestern Accepting Nominations for $200,000 Nemmers Prize in Medical Science
Northwestern University is accepting nominations for its $200,000 Mechthild Esser Nemmers Prize in Medical Science, a biennial prize that will be awarded in Fall 2022.
-
Transforming Lung Cells Critical for Pulmonary Fibrosis
The failure of epithelial cells to complete a stem cell-like transition may lead to pulmonary fibrosis, according to a Northwestern Medicine study.
-
Scientists Develop First Wireless Sensors to Monitor Pregnant Women and their Babies
A new wearable device developed at Northwestern measures mothers’ and babies’ vital signs and data that cannot be collected with current technology.
-
Krainc to receive $9 Million, 8-year NIH Grant
Dimitri Krainc, MD, PhD, has received a Research Program Award grant from the National Institute of Neurological Disorders and Stroke (NINDS).
-
Uncovering Epigenetic Mechanisms Underlying Cancer Development
Two Northwestern Medicine studies are improving the understanding of epigenetic mechanisms in cancer development and progression, and identifying novel cancer driver genes that may help identify patients who will benefit from immunotherapy.
-
Wearable Sensor Tracks Pediatric Eczema, Adult Itch Symptoms
A new wearable sensor that actually quantifies itch by measuring scratching when placed on the hand has been developed by Northwestern University scientists.
-
Investigators to Explore Circadian Rhythms in Cancer and Aging
A team of Northwestern Medicine investigators led by Rina Fox, PhD, MPH, received a Cancer and Aging Translational Bridge Award to investigate circadian disruption in lymphoma.
-
Mitochondria Play Key Role in Lymphatic Development
Mitochondria play a key role in forming the lymphatic vasculature by acting as a metabolic sensor during the migration of lymphatic progenitor cells from the veins.
-
Northwestern Named Network of the National Library of Medicine Evaluation Center
Galter Health Sciences Library and Learning Center has been named the National Evaluation Center for the Network of the National Library of Medicine, a five-year, $4 million award.
-
Drug Demonstrates Poor Efficacy in Advanced Bladder Cancer
An FDA-approved monoclonal antibody drug used to treat advanced bladder cancer demonstrated poor efficacy in a recent clinical trial.
